Lionheart Health Named as Top 40 Semi-Finalist in $101M XPRIZE Healthspan Competition

100 Teams in the XPRIZE Healthspan Competition

One of the challenges inherent in developing an industry of medical development aimed at the treatment of aging is that present regulatory structure and investment culture actively discourage any attempt to quantify effects on life span. While aging clocks are interesting, they cannot yet be relied upon, and no-one is willing to fund the lengthy studies needed to assess the effects of any given therapy on long term health the old-fashioned way, …

Lionheart Health Named as Top 40 Semi-Finalist in $101M XPRIZE Healthspan Competition

Newport Beach, California (Newsworthy.ai) Wednesday May 21, 2025 @ 5:00 AM Pacific — Lionheart Health, Inc., an Orange County, California-based biotechnology company, has been named one of the 40 semi-finalists advancing in the $101M XPRIZE Healthspan Competition at the Longevity Investors Summit in New York City. The mission of XPRIZE is to inspire and empower humanity to achieve breakthroughs that accelerate an abundant and equitable future fo…